|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q3 FY2013
As of Sep 30, 2013
|
Q2 FY2013
As of Jun 30, 2013
|
Q1 FY2013
As of Mar 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
Q3 FY2012
As of Sep 30, 2012
|
Q2 FY2012
As of Jun 30, 2012
|
Q1 FY2012
As of Mar 31, 2012
|
Q4 FY2011
As of Dec 31, 2011
|
Q3 FY2011
As of Sep 30, 2011
|
Q2 FY2011
As of Jun 30, 2011
|
Q1 FY2011
As of Mar 31, 2011
|
Q4 FY2010
As of Dec 31, 2010
|
Q3 FY2010
As of Sep 30, 2010
|
Q2 FY2010
As of Jun 30, 2010
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||
| Current assets: | ||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||
| Restricted cash | ||||||||||||||||||
| Short-term investments | ||||||||||||||||||
| Trade accounts receivable | ||||||||||||||||||
| Inventory | ||||||||||||||||||
| Prepaid antigen costs | ||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||
| Total current assets | ||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||
| Long-term investments | ||||||||||||||||||
| Other assets | ||||||||||||||||||
| Total assets | ||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) | ||||||||||||||||||
| Current liabilities: | ||||||||||||||||||
| Accounts payable | ||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||
| Accrued compensation | ||||||||||||||||||
| Restructuring and contract termination liabilities | ||||||||||||||||||
| Restructuring, contract termination and advisory liabilities | ||||||||||||||||||
| Current portion of convertible debt | ||||||||||||||||||
| Current portion of capital lease obligations | ||||||||||||||||||
| Current portion of facility lease obligations | ||||||||||||||||||
| Total current liabilities | ||||||||||||||||||
| Long-term accrued liabilities | ||||||||||||||||||
| Capital lease obligations, less current portion | ||||||||||||||||||
| Facility lease obligations, less current portion | ||||||||||||||||||
| Convertible senior subordinated notes due 2014 | ||||||||||||||||||
| Convertible senior notes due 2016 | ||||||||||||||||||
| Convertible senior notes due 2016, net of discount | ||||||||||||||||||
| Stockholders' deficit: | ||||||||||||||||||
| Common stock, $0.001 par value; 250,000,000 shares authorized, 158,859,497 and 157,274,622 shares issued and outstanding at September 30,2014 and December 31, 2013, respectively | ||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||
| Total stockholders' deficit | ||||||||||||||||||
| Total liabilities and stockholders' deficit | ||||||||||||||||||
Loading...
